Disclosure Of Cash Flow Statement [Text Block]

Pharming Group N.V. - Filing #5829944

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Disclosure of cash flow statement [text block]
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
54,944,000 USD
61,741,000 USD
207,342,000 USD
Income taxes paid (refund) [abstract]
Income taxes paid (refund), classified as operating activities
15,584,000 USD
655,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.